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Although peripheral axons can regenerate after nerve transection and repair, functional recovery is usually poor due to inaccurate
reinnervation. Neurotrophic factors promote directional guidance to regenerating axons and their selective application may help
to improve functional recovery. Hence, we have characterized in organotypic cultures of spinal cord and dorsal root ganglia the
effect of GDNF, FGF-2, NGF, NT-3, and BDNF at different concentrations onmotor and sensory neurite outgrowth. In vitro results
show that GDNF and FGF-2 enhanced both motor and sensory neurite outgrowth, NGF and NT-3 were the most selective to
enhance sensory neurite outgrowth, and high doses of BDNF selectively enhanced motor neurite outgrowth. Then, NGF, NT-3,
and BDNF (as the most selective factors) were delivered in a collagen matrix within a silicone tube to repair the severed sciatic
nerve of rats. Quantification of Fluorogold retrolabeled neurons showed that NGF and NT-3 did not show preferential effect on
sensory regeneration whereas BDNF preferentially promotedmotor axons regeneration.Therefore, the selective effects of NGF and
NT-3 shown in vitro are lost when they are applied in vivo, but a high dose of BDNF is able to selectively enhance motor neuron
regeneration both in vitro and in vivo.
1. Introduction
After peripheral nerve injury, transected axons can regenerate
and reinnervate target organs. However, reinnervation of
distal organs and functional recovery are often deficient
because random regeneration of axons results in aberrant
target reinnervation [1]. Thus, specificity of reinnervation is
a key issue to improve functional recovery after peripheral
nerve injuries.
Although some studies described that motor axons pref-
erentially reinnervate muscular pathways [2], this accuracy
is compromised when optimal conditions such as pure
muscular and cutaneous branches, matching distal nerve
caliber, and short separation between nerve stumps are not
met [3, 4]. It has been suggested that although motor or
sensory neurons tend to regenerate through their original
pathway, axons sense the levels of trophic factors in distal
branches and then grow towards the target that offers more
trophic support [5]. In fact, some authors argue that the key
point for preferential attraction of axons to their adequate
targets is the expression of trophic factors by their own target
organ and the distal stump [2, 3].
After nerve injury, in order to support neuronal survival
and enhance regeneration, motoneurons in spinal cord (SC)
and sensory neurons in dorsal root ganglia (DRG) synthe-
size and secrete neurotrophic factors (NTFs). Furthermore,
within the proximal and the distal nerve stumps, denervated
Schwann cells become growth supportive and secrete several
NTF and cytokines that follow different patterns of expres-
sion, with an initial upregulation of NGF, BDNF, and GDNF,
whereas others, such as NT-3 or CNTF, are downregulated
[6]. However, changes in NTF levels are severalfold higher at
the lesion area than in the SC or the DRG where the somata
of the axotomized neurons are located [7]. Moreover, it has
been described that some NTF may influence the direction
of regenerating axons on certain models of regeneration
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[8]. Thus, modifying the regenerative microenvironment is
a promising approach to modulate and selectively enhance
sensory and motor regeneration.
However, high levels of NTF or a prolonged delivery over
time can in fact induce no improvement or even result in
deleteriousness in terms of regeneration [9–11], inducing neu-
rotoxicity [12] and endoneurial sprouting and hyperalgesia
[13]. Therefore, as low levels of NTF may not reach ther-
apeutical action and high levels may disrupt regeneration,
a comparative study of the concentrations and delivery of
NTF to specifically improve regeneration ofmotor or sensory
neurons was undertaken. We analyzed the effect of GDNF,
FGF-2, NGF, NT-3, and BDNF at different concentrations on
motor and sensory axonal regeneration using in vitro and in
vivo models.
2. Materials and Methods
2.1. Ethical Guidelines. Both in vitro and in vivo experimental
procedures were approved by the Ethical Committee of
the Universitat Auto`noma de Barcelona in accordance with
the European Communities Council Directive 2010/63/EU.
Adult rats were anaesthetized with pentobarbital sodium
(40mg/kg i.p.). P7 and adult rats were euthanized by pento-
barbital sodium overdose (200mg/kg i.p.).
2.2. DRG and SCOrganotypic Cultures. Organotypic cultures
were prepared as previously described [14]. Briefly, collagen I
(rat tail, #354236, Corning) diluted in basal Eagle’s medium
(Gibco) and sodium bicarbonate at 0.3mg/mL was prepared
as control condition. NGF, NT-3, GDNF, and BDNF (Pepro-
tech) were added to achieve concentrations of 5, 10, 50, or
100 ng/mL. As FGF-2 has been reported to work at higher
concentrations [15], FGF-2 18 kDa (Peprotech) was prepared
at 25, 50, 250, and 500 ng/mL. Finally, 30 𝜇L single drops
of the prepared matrices were deposited on poly-d-lysine
(1 g/mL, Sigma) coated 24-well multidishes (Iwaki, Asahi
Technoglass, Chiba, Japan) and were left to gel for 2 h at 37∘C
and 5% CO
2
in the incubator.
SC lumbar segments and lumbar DRG were harvested
from 7-day-old Sprague-Dawley rats, placed in 4∘C Gey’s
balanced salt solution (Sigma) enriched with 6mg/mL glu-
cose and cleaned from blood and meningeal debris. SCs
were cut with a McIlwain Tissue Chopper in 350 𝜇m thick
slices. SC slices and DRG explants were placed on top of
the collagen matrix and covered by a second 30 𝜇L drop of
the same solution. After 45min in the incubator, samples
were embedded with 0.5mL of neurobasal medium (Life
Technologies), supplemented with B27 (Life Technologies)
and glutamine and penicillin/streptomycin (Sigma). After
one day in culture, the medium of SC cultures was removed
and changed by a penicillin/streptomycin-freemedium.DRG
explants were cultured for 2 days and SC slices for 4 days.
A detailed description of this protocol has been previously
reported [16].
2.3. Neurite Outgrowth Analysis. SC and DRG cultures were
fixed with 4% paraformaldehyde in PBS for 30min. After-
wards, SC and DRG samples were incubated for 48 h with
primary antibody mouse RT97 (1 : 200, Developmental Stud-
ies Hybridoma Bank) at 4∘C. After three hours of washing,
the sections were incubated with secondary antibody AF594
conjugated donkey anti-mouse (1 : 200, Life Technologies)
overnight at 4∘C. After two more washes, samples were
mounted on slides with Mowiol. Cultures were visualized
with an Olympus BX51 fluorescence microscope; images of
different areas were taken with a DP50 camera attached to
a computer with Cell A software (Olympus) and merged
using Adobe Photoshop CS3 (Adobe System). Whole culture
images were analyzed with the Neurite-J plug-in [17] for
ImageJ software [18] and the number of neurites grown at
different distances from the explant was compared between
different conditions of the cultures. The area under the curve
(AUC) for each groupwas calculated by the linear trapezoidal
method using the amount of neurites every 25𝜇m.
2.4. In Vivo Study of Peripheral Nerve Regeneration. Only
the NTFs which showed trophic selectivity for motor and
sensory outgrowth were further tested in vivo. Thus, NGF,
NT-3, and BDNF at 1, 2, and 10 𝜇g/mL each were added to a
2mg/mL collagen solution prepared as above.Thesemixtures
were used to fill silicone tubes (8mm long, 3mm wide, and
2mm i.d.) that were maintained vertically for 12 h to promote
collagen fibril alignment during gel formation [19]. A collagen
matrix without NTF was used in the control group.
Female Sprague-Dawley rats weighing 250–300 g (𝑛 =
4 group) were anaesthetized, the sciatic nerve was exposed
at the midthigh and sectioned 90mm from the tip of the
third toe, and a 6mm nerve portion distal to the section
was resected. The prepared tube was then sutured with 10-
0 monofilament sutures to each nerve end leaving a 6mm
gap between nerve stumps. Animals were left to recover on
a warming pad and then housed with littermates. They were
kept on standard laboratory conditionswith a light-dark cycle
of 12 : 12 h and ad libitum access to food and tap water. All
efforts were made to minimize pain and animal discomfort
during surgery and recovery.
2.5. Retrograde Labeling and Neuronal Counting. Rats were
anesthetized 20 days after operation with pentobarbital
sodium; the sciatic nerve was exposed and transected 8mm
distal to the distal end of the silicone tube. Then, the tip of
the severed nerve was soaked into 5 𝜇L Fluorogold (FG; 5%;
Fluorochrome Inc.) for 1 h in a Vaseline well. After retrieval
of the well, saline was flushed to clean remnants of the tracer
before suturing the wound in planes. Seven days later, the rats
were deeply anesthetized and transcardially perfusedwith 4%
paraformaldehyde in PBS. The lumbar segment (L3–L6) of
the SC and L4 and L5 DRG were removed, postfixed in the
same fixative solution for 1 h, and transferred to 30% sucrose
in PBS. The SC and DRG were cut longitudinally in 40 and
20𝜇m thick sections, respectively, in a cryostat and mounted
on slides. Sections were observed with an Olympus BX51
fluorescence microscope under UV light and the number of
labeled neurons was counted in every third section following
the fractionator principle [20].
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2.6. Data Analysis. Data are presented as mean ± SEM.
Results were statistically analyzed by using GraphPad Prism
(GraphPad Software, USA). Student’s 𝑡-test and one-way
ANOVA followed by Bonferroni’s post hoc test for compar-
ison between groups were used when applicable. Statistical
significance was considered when 𝑝 value was < 0.05.
3. Results and Discussion
BDNF, NGF, NT-3, GDNF, and FGF-2 at different concen-
trations were tested to elucidate the optimal concentration
of each NTF that is able to enhance either motor or sensory
neurite outgrowth without affecting the other neuronal pop-
ulation. For that purpose, 3Dorganotypic cultures of SC slices
and DRG were used (Figures 1–3).
3.1. GDNF and FGF-2 Enhance Both Motor and Sensory
Neurite Outgrowth. Almost all doses of both FGF-2 and
GDNF increased motor and sensory neurite outgrowth with
respect to the control substrate (Figure 1). Regarding motor
neurite outgrowth, FGF-2 showed a progressive dose effect
with the lowest concentrations not being able to reach
significant differences versus the control group (Figures 1(g)
and 1(i)), while GDNF enhanced motor neurite outgrowth
with no dose-dependency as all the groups exhibit similar
curves (Figures 1(h) and 1(j)). On the other hand, sensory
neurites growth from DRG increased similarly at all the
tested concentrations of FGF-2 (Figures 1(k) and 1(m)),
while GDNF followed a dose-dependent increase showing
the high doses even significantly larger AUC values than
the low ones (Figure 1(n)). Comparatively, using the data
of the AUC in each culture condition, FGF-2 promoted a
maximum increase of about 9 and 3 times in neurite growth
of both motor and sensory neurites, whereas GDNF induced
maximal increase of 11 and 8 times baseline, respectively
(Figures 4(a) and 4(b)).
These results in vitro reveal that neither GDNF nor FGF-
2 show a preference for motor or sensory neuritogenesis,
as both neuronal populations are enhanced at the different
concentrations used.While GDNF has already been reported
to promote neurite outgrowth of both populations, FGF-
2 was described to preferentially enhance motor neurite
outgrowth when measuring the length of longest neurites
[15]. Since reliable measurements of neurite outgrowth anal-
ysis in organotypic cultures are complicated [21], we used
a semiautomatic analysis that works as an adaption of the
Sholl method [17] to improve accuracy and reproducibility
as shown in other works [22, 23]. Thus, the differences
in methods and variables to quantify neurite outgrowth in
these studies may in fact explain some controversies. Hence,
in accordance with our results, we discarded GDNF and
FGF-2 for in vivo studies because of their lack of selective
effect.
3.2. NGF and NT-3 Selectively Enhance Sensory Regeneration
In Vitro but Not In Vivo. Observation of cultures of SC slices
and DRG with NGF and NT-3 (Figures 2(a)–2(f)) revealed
they were the most selective tested factors for sensory regen-
eration. Motor neurite outgrowth was not affected by NGF or
NT-3 at any of the concentrations compared to the control
cultures (Figures 2(g)–2(j)). In contrast, addition of NGF
(Figures 2(k) and 2(m)) or NT-3 (Figures 2(l) and 2(n)) in
the collagenmatrix yieldedmore sensory neurites at different
distances and larger values of the AUC in comparison with
controls (Figures 2(m) and 2(n)), the 50 ng/mL dose being
the one that showed the highest values for NGF and NT-3. In
agreement with previous studies [24], NGF andNT-3 are able
to promote exclusively sensory neurite outgrowth, without
enhancing motor axon regeneration from SC slices (Figures
4(c) and 4(d)). This selective effect may be explained because
motoneurons do not express TrkA receptor and after nerve
injury the expression levels of TrkC receptor remain relatively
unchanged [7].
Taking advantage of the differential promotion of sensory
but not motor neurite outgrowth, these NTFs were tested in
vivo in a model of nerve regeneration. 20 days after section of
the sciatic nerve and tube repair, all the rats showed evidence
of axonal regeneration, as judged by the retrograde labeling of
motor (Figures 5(a) and 5(b)) and sensory (Figures 5(c) and
5(d)) regenerated neurons. Concerning motor axon regener-
ation, both NGF and NT-3 groups unexpectedly improved
motor axon regeneration at all doses (Figure 5(e)). Indeed,
although some studies have already described that NGF
administration in a fibrin depot improvesmotor regeneration
[25], the common belief is that NGF andNT-3 are prosensory
NTFs [6]. Regarding sensory neurons, as expected, NGF and
NT-3 groups showed a significantly increased number of
regenerated neurons at all doses, except the lowest of NT-3
(1 𝜇g/mL) (Figure 5(f)).
Thus, in vivo results with NGF and NT-3 seem to contra-
dict the in vitro observations where only sensory neurite out-
growthwas improved. Differences between the in vitro and in
vivo models should be first taken into account. Organotypic
cultures are multicellular in vitro models, in which neurons
remain embedded in contact with accompanying glial cells.
Although Schwann cells and fibroblasts migrate outside the
slice in organotypic cultures interacting with and giving
structural support to the newborn neurites [26], the amount
and activation of these cells are probably lower than in vivo
conditions in which cells from the cut nerve stumps migrate
inside the tube to stimulate nerve regeneration. In addition,
the recruitment of hematogenous inflammatory cells that
plays an important role during Wallerian degeneration in
vivo is absent in vitro. Another important difference attains
the role of extracellular matrix components. In our in vitro
cultures, the matrix was made of collagen I only, whereas
in vivo reactive Schwann cells and fibroblasts secrete several
neurotropic molecules, including laminin and fibronectin
[6]. It has been shown that neurite outgrowth in response
to neurotrophins, such as NGF, is modulated by the compo-
sition and density of the extracellular matrix modifying the
interactions with supporting Schwann cells [27].
After nerve damage, levels of NGF mRNA rise rapidly
in the nonneuronal cells of the damaged nerve [28]. It is
also known that NGF and other neurotrophins interact not
only with axons but also with Schwann cells and fibroblasts
within the regenerative microenvironment [29]. Taking into
account that Schwann cells dedifferentiate after injury and
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Figure 1: Continued.
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Figure 1: Representative images of RT97 stained neurites from spinal cord slices (a–c) and DRG neurons (d–f) cultured within a 3D collagen
matrix alone (a, d) and with addition of 500 ng/mL of FGF-2 (b, e) or 100 ng/mL of GDNF (c, f). Quantification of the number of neurites
grown at increasing distance from the spinal cord slices (g, h) and from DRG body (k, l) after the addition of FGF-2 and GDNF. Plots of
the quantified AUC from (g), (h), (k), and (l) graphs for motor (i, j) or sensory (m, n) neurite outgrowth. Data expressed as mean ± SEM.
∗𝑝 < 0.05 versus control; #𝑝 < 0.05. Scale bar: 100 𝜇m (a) and 200 𝜇m (b–f).
change their phenotype to a proregenerative state [6, 30],
secreting a variety of tropic and trophic molecules, both NGF
and NT-3 might enhance axonal regeneration indirectly and
indiscriminately by stimulating Schwann cell proliferation
and release of other NTFs such as BDNF or GDNF [31, 32].
3.3. BDNF Selectively Enhances Motor Regeneration In Vitro
and In Vivo. BDNF was the NTF showing the most selective
effect on motoneuron regeneration in vitro (Figure 3). Addi-
tion of BDNF to the medium (Figures 3(b) and 3(c)) showed
an increase in motor neurite outgrowth in comparison
with control values (Figure 3(g)), the 50 ng/mL being the
concentration that produced the highest values in terms
of neurites length (Figure 3(g)) and AUC (Figure 3(h)).
Interestingly, a higher concentration of 100 ng/mL did not
promote neurite growth, suggesting a window of dose effect,
in agreement with previous data [7, 9]. On the other hand,
BDNF slightly enhanced sensory neurite outgrowth only at
low concentrations of 5 and 10 ng/mL (Figures 3(e), 3(i),
and 3(j)) while higher levels reverted this increase. These
results suggest a preferential motor profile for BDNF with a
high dose of BDNF (50 ng/mL) increasing about 10-fold the
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Figure 2: Continued.
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Figure 2: Representative images of RT97 stained neurites from spinal cord slices (a–c) and DRG neurons (d–f) cultured within a 3D collagen
matrix alone (a, d) and with addition of 50 ng/mL of NGF (b, e) or NT-3 (c, f). Quantification of the number of neurites grown at increasing
distance from the spinal cord slices (g, h) and from DRG body (k, l) after the addition of NGF and NT-3. Plots of the quantified AUC from
(g), (h), (k), and (l) graphs for motor (i, j) or sensory (m, n) neurite outgrowth. Data expressed as mean ± SEM. ∗𝑝 < 0.05 versus control;
#𝑝 < 0.05. Scale bar: 200 𝜇m (a–f).
growth of motor neurites from SC slices but without effect on
DRG neurite outgrowth (Figure 4(e)).
Following the in vitro results, we tested if BDNF could
selectively promote motor axon regeneration in vivo after
nerve section and tube repair. Quantification of retrolabeled
neurons revealed that 20 days after surgery all the groups
treated with BDNF had higher number of regenerated motor
neurons than the control group (Figure 5(e)). In parallel
to the in vitro results, BDNF only increased the number
of regenerated sensory neurons at a low dose (1𝜇g/mL)
while higher doses gave similar result to the control group
(Figure 5(f)).
The BDNF receptor TrkB is expressed constitutively in
motoneurons and its levels increase after injury [7], while
intact sensory neurons show low levels of TrkB, although its
expression is also upregulated after injury [33]. Similarly, the
endogenous expression of BDNF is also upregulated in the
distal stump after nerve injury [7]. On the other hand, it
has been suggested that BDNF upregulates TrkB expression
at low doses [34], but high levels of this neurotrophin may
downregulate this receptor in neuronal cells [35]. Thus, it
seems that BDNF can modulate motor axon growth under
a bimodal profile. Indeed, Boyd and Gordon demonstrated
a biphasic effect in which low doses of exogenous BDNF
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Figure 3: Representative images of RT97 stained neurites from spinal cord slices (a–c) and DRG neurons (d–f) cultured within a 3D collagen
matrix alone (a, d) and with addition of 10 ng/mL (b, e) and 50 ng/mL of BDNF (c, f). Quantification of the number of neurites grown at
increasing distance from the cord slices (g) and from DRG body (i) after the addition of different doses of BDNF. Plots of the quantified area
under each curve from (g) and (i) graphs for motor (h) or sensory neurite outgrowth (j). Data expressed as mean ± SEM. ∗𝑝 < 0.05 versus
control; #𝑝 < 0.05. Scale bar: 200 𝜇m (a–f).
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Figure 4: Histogram of the fold increase of the AUC for motor and sensory neurite outgrowth induced by FGF (a), GDNF (b), NGF (c),
NT-3 (d), and BDNF (e) at the concentrations tested compared to the control collagen matrix. Data expressed as mean ± SEM. ∗𝑝 < 0.05.
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Figure 5: Representative micrographs of neurons retrolabeled with FG in the spinal cord (a, b) and DRG (c, d) growing in control conditions
(a, c), with 10𝜇g/mL of BDNF (b) and 10 𝜇g/mL of NGF (d). Histogram of the number of regenerated motor (e) and sensory (f) neurons after
sciatic nerve section and conduit repair with NGF, NT-3, and BDNF at different doses. Data expressed as mean ± SEM. ∗𝑝 < 0.05. Scale bar:
500 𝜇m (a–d).
increased the number of chronically axotomized motoneu-
rons which regenerated their axons whereas high doses pro-
gressively reduced the number [9]. The low doses upregulate
TrkB receptors and enhance both sensory and motor neurite
growth promoting the expression of growth-associated genes
such as tubulin or GAP-43 [36]. In contrast, high doses
would downregulate TrkB receptors, minimizing the effect of
BDNF or even promoting an inhibitory effect via activation
of the p75 receptor [37]. The differential effect of the same
doses on motor and sensory axonal regeneration might be
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explained because of differences in the expression of these
receptors and their contribution to neurotrophin transport
in motor and sensory neurons [38, 39]. On the other hand,
the fact that the high dose of BDNF used in our study in vivo
promotedmotor axon regeneration can be explained because
it is much lower than the doses shown to be inhibitory
when applied by continuous infusion [9]. Other studies have
proved that local release of BDNF increases the number of
regenerated axons through grafts or conduits [40, 41], and a
selective increase in the number of motor axons was noted
with gene-induced BDNF overexpression [42]. At longer
term after sciatic nerve injury and repair, administration of
exogenous BDNF enhanced motor functional recovery in
some studies [41, 43] but not in others [37, 42, 44]. Thus, the
early administration of adequate concentrations of BDNF to
axotomized motoneurons may be sufficient to sustain initial
axon growth, but it may fail to support regeneration and
target reinnervation for long time.
Schwann cells from motor and sensory nerve branches
express different molecular markers that may contribute
to the capacity of axons to specifically regenerate towards
appropriate pathways. Particularly, Schwann cells associated
with motor but not with sensory axons express the HNK1
carbohydrate epitope [45]. In addition, Schwann cells of
sensory and motor nerves respond differently during den-
ervation, by overexpressing different types of NTFs [46].
However, such differences tend to decline with time after
injury, suggesting that the endogenous production of factors
may not contribute enough to the sorting of different types
of axons during nerve regeneration [6]. Interestingly, it has
been shown that the upregulation of HNK-1 induced by
electrical stimulation of the injured nerve is dependent on
BDNF and its receptor TrkB [47], which are also increased
by the electrical stimulation [48]. These observations suggest
one mechanism by which exogenously modulating the local
expression of BDNF may help to attract the regeneration of
motor axons.
4. Conclusion
The results of this study provide a comparative analysis of
the optimal doses for stimulating motor and sensory axonal
regeneration both in vitro and in vivo for different NTFs
(GDNF, FGF-2, NGF, NT-3, and BDNF). Optimal concen-
trations of GDNF and FGF-2 show the highest potentiation
of both motor and sensory neuron regeneration. On the
other hand, NGF and NT-3 show a selective enhancement
of sensory neurite growth in vitro that is lost in our in vivo
model. Finally, BDNF at selected doses selectively promotes
motor axonal growth both in vitro and in vivo.
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